← Home / IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Stock Analysis
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
IOVA
IOVA · Market data
5.02 +0.40%
Track IOVA in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when IOVA price is:
52W Range Position
89%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-07-20 22:10 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 5.41. Holding above 4.12 keeps the current thesis intact.
⚖️
✓
Fundamentals
Strong / Negative
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
4.12
↗
Break Above
Confirmation improves above resistance.
5.41
🎯
Next Objective
Pattern-derived target if setup continues.
5.03
×
Thesis Break
Scenario weakens below invalidation.
Below 4.12
What's Driving IOVA?
📈 Technical recovery is improving
Momentum is Neutral. Watch 5.41 for confirmation and 4.12 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 4.12
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
65.2
Price Chart
IOVA · WOI overlay chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-17
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$2.2B
Company size
EV
$2.0B
Debt-adjusted value
P/E
-6.2
Not meaningful
P/S
7.7
Balanced
P/B
3.0
Balanced
EV/Sales
7.0
Balanced
EV/EBIT
-5.5
Not meaningful
P/FCF
-7.2
Not meaningful
FCF Yield
-13.92%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial pressure is elevated
Financial conditions require selective monitoring.
↗
Revenue Growth
Strong
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Strong
💵 Revenue
71.43M
↗ Strong
📈 Net Income
-79.05M
↘ Negative
🧮 EPS (Basic)
-0.19
↘ Negative
IOVANCE BIOTHERAPEUTICS, INC.
Related Opportunities